Anhui Huangshan Capsule Co Ltd (002817) - Total Assets
Based on the latest financial reports, Anhui Huangshan Capsule Co Ltd (002817) holds total assets worth CN¥1.12 Billion CNY (≈ $163.30 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Anhui Huangshan Capsule Co Ltd - Total Assets Trend (2011–2025)
This chart illustrates how Anhui Huangshan Capsule Co Ltd's total assets have evolved over time, based on quarterly financial data. Also see Anhui Huangshan Capsule Co Ltd market capitalisation for the company's overall valuation and market capitalisation.
Anhui Huangshan Capsule Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Anhui Huangshan Capsule Co Ltd's total assets of CN¥1.12 Billion consist of 36.1% current assets and 63.9% non-current assets. Review 002817 total liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 14.0% |
| Accounts Receivable | CN¥166.32 Million | 15.0% |
| Inventory | CN¥75.76 Million | 6.8% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥17.13 Million | 1.6% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2011–2025)
This chart illustrates how Anhui Huangshan Capsule Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See 002817 stock price and chart for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Anhui Huangshan Capsule Co Ltd's current assets represent 36.1% of total assets in 2025, a decrease from 63.1% in 2011.
- Cash Position: Cash and equivalents constituted 14.0% of total assets in 2025, down from 14.8% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, an increase from 0.0% in 2011.
- Asset Diversification: The largest asset category is accounts receivable at 15.0% of total assets.
Anhui Huangshan Capsule Co Ltd Competitors by Total Assets
Key competitors of Anhui Huangshan Capsule Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
|
Germany | €1.60 Trillion |
|
GALDERMA GROUP AG
NYSE:GALDY
|
USA | $13.39 Billion |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
|
USA | $15.42 Trillion |
|
Beijing Tongrentang Co Ltd
SHG:600085
|
China | CN¥31.82 Billion |
|
Takeda Pharmaceutical Company Limited
F:TKDA
|
Germany | €15.41 Trillion |
|
Changchun High & New Technology Industries Group Inc
SHE:000661
|
China | CN¥30.77 Billion |
|
Neuland Laboratories Limited
NSE:NEULANDLAB
|
India | Rs29.30 Billion |
|
China Resources Double-Crane Pharmaceutical Co Ltd
SHG:600062
|
China | CN¥17.01 Billion |
Anhui Huangshan Capsule Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.08 | 3.98 | 5.05 |
| Quick Ratio | 2.49 | 3.31 | 4.31 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥254.28 Million | CN¥442.72 Million | CN¥470.28 Million |
Anhui Huangshan Capsule Co Ltd - Advanced Valuation Insights
This section examines the relationship between Anhui Huangshan Capsule Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.52 |
| Latest Market Cap to Assets Ratio | 0.25 |
| Asset Growth Rate (YoY) | 2.0% |
| Total Assets | CN¥1.11 Billion |
| Market Capitalization | $275.74 Million USD |
Valuation Analysis
Below Book Valuation: The market values Anhui Huangshan Capsule Co Ltd's assets below their book value (0.25x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Anhui Huangshan Capsule Co Ltd's assets grew by 2.0% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Anhui Huangshan Capsule Co Ltd (2011–2025)
The table below shows the annual total assets of Anhui Huangshan Capsule Co Ltd from 2011 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥1.11 Billion ≈ $162.12 Million |
+1.97% |
| 2024-12-31 | CN¥1.09 Billion ≈ $158.99 Million |
-1.50% |
| 2023-12-31 | CN¥1.10 Billion ≈ $161.42 Million |
+6.30% |
| 2022-12-31 | CN¥1.04 Billion ≈ $151.85 Million |
-1.53% |
| 2021-12-31 | CN¥1.05 Billion ≈ $154.21 Million |
+15.07% |
| 2020-12-31 | CN¥915.81 Million ≈ $134.01 Million |
+10.10% |
| 2019-12-31 | CN¥831.80 Million ≈ $121.72 Million |
+6.64% |
| 2018-12-31 | CN¥780.03 Million ≈ $114.14 Million |
+5.59% |
| 2017-12-31 | CN¥738.73 Million ≈ $108.10 Million |
+5.63% |
| 2016-12-31 | CN¥699.36 Million ≈ $102.34 Million |
+69.34% |
| 2015-12-31 | CN¥413.00 Million ≈ $60.43 Million |
+18.00% |
| 2014-12-31 | CN¥349.99 Million ≈ $51.22 Million |
+7.34% |
| 2013-12-31 | CN¥326.07 Million ≈ $47.71 Million |
+23.59% |
| 2012-12-31 | CN¥263.82 Million ≈ $38.61 Million |
+33.14% |
| 2011-12-31 | CN¥198.15 Million ≈ $29.00 Million |
-- |
About Anhui Huangshan Capsule Co Ltd
Anhui Huangshan Capsule Co., Ltd. engages in the research and development, production, and sale of gelatin and enteric-coated gelatin empty capsules in China. The company offers pullulan capsules, entersoluble vacant gelatin capsules, vacant gelatin capsules, vegetable entersoluble capsules, colonsoluble vacant gelatin capsules, hydroxypropyl methyl cellulose hollow capsules, and hydroxypropyl st… Read more